UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRL
1451
DELISTED
Control4 Corporation
CTRL
| $1.26M | ﹤0.01% |
64,500
| – | – |
|
1452
Synaptics
SYNA
$4.16B
| $1.26M | ﹤0.01% |
13,899
+600
| +5% | +$40.7K |
|
1453
Manhattan Associates
MANH
$11.2B
| $1.26M | ﹤0.01% |
36,500
| – | – |
|
1454
Nice
NICE
$5.82B
| $1.25M | ﹤0.01% |
30,680
-104,339
| -77% | -$4.32M |
|
|
ALX
1455
Alexander's
ALX
$1.42B
| $1.24M | ﹤0.01% |
3,354
+100
| +3% | +$35.8K |
|
1456
WaFd
WAFD
$2.79B
| $1.23M | ﹤0.01% |
54,996
-6,471
| -11% | -$142K |
|
1457
Sumitomo Mitsui Financial
SMFG
$161B
| $1.23M | ﹤0.01% |
145,211
+4,611
| +3% | +$38K |
|
1458
Moog Inc Class A
MOG.A
$12.9B
| $1.22M | ﹤0.01% |
16,799
+3,400
| +25% | +$234K |
|
1459
Sprouts Farmers Market
SFM
$7.94B
| $1.22M | ﹤0.01% |
+37,400
| New | +$1.16M |
|
|
CADE
1460
DELISTED
Cadence Bank
CADE
| $1.22M | ﹤0.01% |
49,597
| – | – |
|
1461
NorthWestern Energy
NWE
$4.25B
| $1.22M | ﹤0.01% |
23,280
| – | – |
|
1462
PBF Energy
PBF
$7.25B
| $1.21M | ﹤0.01% |
45,300
+17,000
| +60% | +$503K |
|
1463
ONE Gas
OGS
$4.97B
| $1.2M | ﹤0.01% |
31,899
-5,393
| -14% | -$197K |
|
1464
Silgan Holdings
SLGN
$4.51B
| $1.2M | ﹤0.01% |
47,392
-263,800
| -85% | -$6.54M |
|
|
ATHL
1465
DELISTED
ATHLON ENERGY INC COM
ATHL
| $1.2M | ﹤0.01% |
25,200
+13,300
| +112% | +$558K |
|
|
TXNM
1466
TXNM Energy Inc
TXNM
$5.91B
| $1.2M | ﹤0.01% |
40,897
| – | – |
|
|
UNS
1467
DELISTED
UNS ENERGY CORP COM
UNS
| $1.2M | ﹤0.01% |
19,799
| – | – |
|
1468
U-Haul Holding Co
UHAL
$14.5B
| $1.19M | ﹤0.01% |
41,000
| – | – |
|
1469
PRA Group
PRAA
$672M
| $1.19M | ﹤0.01% |
20,000
| – | – |
|
1470
Radian Group
RDN
$5.21B
| $1.19M | ﹤0.01% |
80,294
+3,000
| +4% | +$43.7K |
|
1471
Penske Automotive Group
PAG
$14.2B
| $1.19M | ﹤0.01% |
23,999
| – | – |
|
1472
Black Hills Corp
BKH
$5.46B
| $1.19M | ﹤0.01% |
19,299
| – | – |
|
1473
Jack in the Box
JACK
$351M
| $1.19M | ﹤0.01% |
19,799
| – | – |
|
|
ACH
1474
Accendra Health
ACH
$227M
| $1.18M | ﹤0.01% |
34,869
+300
| +0.9% | +$10.3K |
|
1475
Tyler Technologies
TYL
$12.6B
| $1.18M | ﹤0.01% |
12,899
+400
| +3% | +$32.4K |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.